HR 4101 119th Congress House Health

Cancer Drug Parity Act of 2025

Introduced: March 16, 2026 Introduced by: Grothman, Glenn Republican · Wisconsin See on congress.gov

Everywhere this bill has been 2 steps

Introduced

In committee

Reported out

Passed House

Passed Senate

To President

Became law

Jun 24, 2025

Referred to the House Committee on Education and Workforce.

Jun 24, 2025

Introduced in House

Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

What's happening now June 24, 2025

Referred to the House Committee on Education and Workforce.

Bill text 1 version

Introduced in House Formatted Text PDF Formatted XML

Source documents hosted by congress.gov.

Committees of jurisdiction 1

Education and Workforce Committee
House of Representatives

Lobbying activity 11

Registered lobbyists who named this bill in their disclosure filings. Source: federal Lobbying Disclosure Act filings.

CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
for HEMATOLOGY ONCOLOGY PHARMACY ASSOCIATION · Wisconsin · 2nd Quarter (Apr 1 - June 30) 2026
ASSOCIATION FOR CLINICAL ONCOLOGY
for ASSOCIATION FOR CLINICAL ONCOLOGY · Virginia · 2nd Quarter (Apr 1 - June 30) 2026
ASSOCIATION FOR CLINICAL ONCOLOGY
for ASSOCIATION FOR CLINICAL ONCOLOGY · Virginia · 1st Quarter (Jan 1 - Mar 31) 2026
THE SUSAN G. KOMEN BREAST CANCER FOUNDATION, INC. DBA SUSAN G. KOMEN
for THE SUSAN G. KOMEN BREAST CANCER FOUNDATION, INC. DBA SUSAN G. KOMEN · Texas · 4th Quarter (Oct 1 - Dec 31) 2025
ASSOCIATION FOR CLINICAL ONCOLOGY
for ASSOCIATION FOR CLINICAL ONCOLOGY · Virginia · 4th Quarter (Oct 1 - Dec 31) 2025
ASSOCIATION FOR CLINICAL ONCOLOGY
for ASSOCIATION FOR CLINICAL ONCOLOGY · Virginia · 3rd Quarter (July 1 - Sep 30) 2025

See all 11 filings →

Cosponsors 27

Schmidt, Derek

Kansas · Mar 16, 2026

Neguse, Joe

Colorado · Dec 18, 2025

Pappas, Chris

New Hampshire · Dec 18, 2025

Bynum, Janelle S.

Oregon · Nov 7, 2025

Conaway, Herbert C.

New Jersey · Nov 7, 2025

Salinas, Andrea

Oregon · Nov 7, 2025

Jackson, Jonathan L.

Illinois · Oct 24, 2025

Houlahan, Chrissy

Pennsylvania · Oct 21, 2025

Garamendi, John

California · Oct 17, 2025

Ross, Deborah K.

North Carolina · Oct 8, 2025

Vindman, Eugene Simon

Virginia · Oct 3, 2025

Bresnahan, Robert P.

Pennsylvania · Sep 30, 2025

Balint, Becca

Vermont · Sep 15, 2025

Norton, Eleanor Holmes

District of Columbia · Sep 15, 2025

Raskin, Jamie

Maryland · Sep 9, 2025

Castor, Kathy

Florida · Jun 25, 2025

Kennedy, Timothy M.

New York · Jun 25, 2025

Bilirakis, Gus M.

Florida · Jun 24, 2025

Bonamici, Suzanne

Oregon · Jun 24, 2025

Brownley, Julia

California · Jun 24, 2025

Davids, Sharice

Kansas · Jun 24, 2025

Davis, Donald G.

North Carolina · Jun 24, 2025

Fitzpatrick, Brian K.

Pennsylvania · Jun 24, 2025

Matsui, Doris O.

California · Jun 24, 2025

Moore, Gwen

Wisconsin · Jun 24, 2025

Morelle, Joseph D.

New York · Jun 24, 2025

Wilson, Joe

South Carolina · Jun 24, 2025

Cite this page click to expand

APA

U.S. Congress. (2026). H.R. 4101: Cancer Drug Parity Act of 2025. 119th Congress. Open America. https://openamerica.io/bill/119-HR-4101/

MLA

"H.R. 4101: Cancer Drug Parity Act of 2025." 119th Congress, 2026, Open America, https://openamerica.io/bill/119-HR-4101/.

Bluebook (legal)

H.R. 4101, 119th Cong. (2026), https://openamerica.io/bill/119-HR-4101/.

Markdown link

[H.R. 4101: Cancer Drug Parity Act of 2025](https://openamerica.io/bill/119-HR-4101/)